Popular Trials
Readmission Reduction Interventions for Sepsis or Pneumonia
This trial is testing different care models to see which one is better at preventing readmissions for patients who have been hospitalized with sepsis or lower respiratory tract infection. The primary outcome is the number of days spent at home within 90 days after hospital discharge.
Behavioural Intervention
Exercise Therapy for Cancer and COVID-19 Recovery
This trial will evaluate the safety of an aerobic exercise therapy program for cancer patients recovering from COVID-19. The therapy being used is a walking program that will be adjusted to match participant fitness levels.
Immune Activation Imaging for COVID-19
This trial involves injecting a special substance into people who have recovered from COVID-19 and then taking detailed body scans to see where the substance goes. This helps doctors understand how different parts of the body are affected after recovering from COVID-19.
Popular Filters
Trials With No Placebo
Cannabinoid
Medical Cannabis for Chronic Pain
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Behavioral Intervention
Onsite COVID-19 Testing for Criminal Justice-Involved Individuals
This trial will help to establish if an onsite Point-of-Care SARS-CoV-2 testing and education strategy can help reduce community transmission by improving testing uptake, mitigation behaviors, and vaccine uptake among criminal justice-involved individuals.
Frequently Asked Questions
Introduction to covid19
What are the top hospitals conducting covid19 research?
In the battle against the global COVID-19 pandemic, hospitals and research centers have been at the forefront of scientific innovation. One such institution leading the charge is the University of Minnesota in Minneapolis. With five active clinical trials focused on COVID-19, this renowned hospital is dedicated to finding effective treatments and solutions for this unprecedented health crisis. Similarly, Sunnybrook Health Sciences Centre in Toronto is making significant contributions with three ongoing trials aimed at combating COVID-19. Located in Tampa, Florida, Tampa General Hospital joins the effort with three active clinical trials as well. Meanwhile, UF Health Precision Health Research located in The Villages community also has three current studies underway to aid our understanding and ability to combat this virus effectively. Lastly, Morehouse School of Medicine based in Atlanta proudly contributes its expertise through three active clinical trials targeting COVID-19.
Although these hospitals may not have any completed or all-time recorded trials specific to COVID-19 yet due to its recent emergence as a global threat; their commitment exemplifies an unwavering determination toward developing strategies that can save lives during this challenging time. By conducting rigorous research and enrolling patients into these innovative studies, these institutions are paving the way for groundbreaking breakthroughs that will shape our future response to pandemics like never before seen
Which are the best cities for covid19 clinical trials?
When it comes to COVID-19 clinical trials, several cities have emerged as hubs of research and development. Chicago, with 14 active trials, is investigating treatments such as Nitazoxanide and SARS-CoV-2 rS/Matrix-M1 Adjuvant. Miami follows closely behind with 13 ongoing studies focused on interventions like Fluvoxamine and SARS-CoV-2 rS/Matrix-M1 Adjuvant. Toronto also plays a significant role in COVID-19 research, with 11 active trials exploring methods such as PRONE POSITIONING and Sevoflurane inhalant product. New york City and Philadelphia are also notable cities for COVID-19 clinical trials, conducting investigations into various treatment options. These cities collectively provide individuals affected by the pandemic access to cutting-edge clinical trials that contribute to advancing our understanding of the virus and potential treatments for better outcomes.
Which are the top treatments for covid19 being explored in clinical trials?
Researchers are leaving no stone unturned in the quest for effective treatments against COVID-19. At the forefront of clinical trials, several potential game-changers have emerged. Here are a few leading contenders:
- Remdesivir: A widely studied antiviral drug showing promise in mitigating severe symptoms.
- Tocilizumab: An immunosuppressive medication that aims to counteract harmful inflammation caused by the virus.
- Convalescent plasma therapy: The transfusion of antibody-rich plasma from recovered COVID-19 patients with hopes of boosting immunity.
As scientists continue their relentless efforts, these treatments offer glimpses of hope amidst the ongoing battle against this global pandemic.
What are the most recent clinical trials for covid19?
Recent clinical trials for COVID-19 have brought forth promising advancements in the fight against this global pandemic. Notably, significant attention has been given to the potential benefits of metformin, an existing medication used for diabetes management, in mitigating the impact of COVID-19. Another trial focused on intravenously delivering MSC-exosomes every other day at escalating doses, displaying encouraging results during phases 1 and 2. Additionally, Azelastine has been investigated as a treatment option for COVID-19 in a Phase 4 trial. These developments indicate that progress is being made towards finding effective interventions to combat this unprecedented health crisis.
What covid19 clinical trials were recently completed?
Several recent clinical trials have made significant progress in advancing our understanding and treatment of COVID-19. Notably, a trial for the antiviral drug Remdesivir concluded successfully, providing valuable insights into its effectiveness against the virus. Another important trial investigated the use of convalescent plasma therapy, which utilizes antibodies from recovered COVID-19 patients to treat those currently infected. Additionally, a study explored the potential benefits of dexamethasone as an anti-inflammatory treatment for severe cases of COVID-19. These completed trials contribute to our ongoing fight against the pandemic by informing medical strategies and improving patient outcomes.